Benjamin Edwards’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
Benjamin Edwards's GSK Position: Q3 2026 in Review
Benjamin Edwards increased its GSK (GSK) stake by 21% in Q3 2026, buying an estimated $59.4K and bringing the position to 6,833 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #1221.
Benjamin Edwards first reported a position in GSK in Q1 2022 and has held it in 12 quarters since. The position peaked at $1M in Q3 2025. 854 funds tracked by Wall St. Rank hold GSK as of Q3 2026.
- Benjamin Edwards held 6,833 shares of GSK worth $329K as of Q3 2026.
- Benjamin Edwards bought 1,163 GSK shares in Q3 2026, an estimated $59.4K.
- GSK made up ﹤0.01% of Benjamin Edwards's portfolio in Q3 2026, its #1221 holding.
- Benjamin Edwards first reported a position in GSK in Q1 2022 and has held it in 12 quarters since.
- Benjamin Edwards's GSK position peaked at $1M in Q3 2025.
- 854 funds tracked by Wall St. Rank held GSK as of Q3 2026.
Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.